UroGen Pharma Ltd.

URGN · Healthcare · UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty can…

UroGen Pharma Ltd. (URGN), in the Healthcare sector, has 6 disclosed filings on Paydirt over the trailing twelve months from 1 corporate insider: 0 purchases and 6 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 20 and filed Aug 24. The most active filer was Mark Schoenberg with 7 filings.

Add to watchlist

Filings, ttm

0 buys · 6 sells

Traders, ttm

1 insider

Volume, ttmiDollar value disclosed in the window

$4.3M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 20

Filed Aug 24

ADViAverage daily dollar volume

$38.9M

market data

Share price · 12M

$43.62 (+142.5%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $4.6M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Mark Schoenberg Chief Medical Officer 7 filings JS

Jason Drew Smith General Counsel 1 filing

Recent filings

Mark SchoenbergSALE Chief Medical Officer $2.9M
60,677 sh × $47.05
Exec Aug 20
Filed Aug 24 · 5:03 PM ET Mark SchoenbergSALE Chief Medical Officer $400K
10,000 sh × $40.00
Exec Jul 9
Filed Jul 10 · 2:17 PM ET Mark SchoenbergSALE Chief Medical Officer $350K
10,000 sh × $35.01
Exec Jun 22
Filed Jun 24 · 5:30 PM ET Mark SchoenbergSALE Chief Medical Officer $143K
5,222 sh × $27.30
Exec Jun 8
Filed Jun 9 · 5:30 PM ET Mark SchoenbergSALE Chief Medical Officer $300K
10,000 sh × $30.00
Exec May 8
Filed May 11 · 5:30 PM ET Mark SchoenbergSALE Chief Medical Officer $250K
10,000 sh × $25.00
Exec Nov 19 2025
Filed Nov 20 2025 · 5:30 PM ET Mark SchoenbergSALE Chief Medical Officer $177K
10,000 sh × $17.69
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET Jason Drew SmithSALE General Counsel $144K
7,522 sh × $19.14
Exec Jul 28 2025
Filed Jul 30 2025 · 5:30 PM ET